| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abnormal Lipoprotein(a) Levels Predict Coronary Artery Calcification in East Asian but Not in White Populations* †
|
Sharma, Abhinav
|
|
2011
|
5 |
3 |
p. 222
|
artikel
|
| 2 |
Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: The Jackson Heart Study
|
Harman, Jane L.
|
|
2011
|
5 |
3 |
p. 173-178
|
artikel
|
| 3 |
A Limited Role for the LDL Receptor Pathway in Regulation of Cholesterol Homeostasis in the Liver
|
Kiss, Robert Scott
|
|
2011
|
5 |
3 |
p. 241
|
artikel
|
| 4 |
A Mediterranean-style low-glycemic-load diet improves variables of metabolic syndrome in women, and addition of a phytochemical-rich medical food enhances benefits on lipoprotein metabolism
|
Jones, Jennifer L.
|
|
2011
|
5 |
3 |
p. 188-196
|
artikel
|
| 5 |
A Meta-Analysis of Randomized Controlled Trials Comparing Lipid Effects of Beef with Poultry and/or Fish Consumption
|
Maki, Kevin Carl
|
|
2011
|
5 |
3 |
p. 217
|
artikel
|
| 6 |
AMR101, a Pure-EPA Omega-3 Fatty Acid, Lowers Triglycerides in Patients with Very High Triglycerides Without Raising LDL-C: The MARINE Study
|
Bays, Harold Edward
|
|
2011
|
5 |
3 |
p. 205
|
artikel
|
| 7 |
Analysis of Knowledge and Barriers to Non-High-Density Lipoprotein Cholesterol Goal Attainment Among Physicians in Training*
|
Negi, Smita Indrasingh
|
|
2011
|
5 |
3 |
p. 238
|
artikel
|
| 8 |
Analysis of Prescribing Patterns for Mixed Dyslipidemia Among Adult Primary Care Physicians and Cardiologists in a Multispecialty Group
|
Uusinarkaus, Kari
|
|
2011
|
5 |
3 |
p. 230
|
artikel
|
| 9 |
A New Ratio for Better Predicting Future Death/Myocardial Infarction than Standard Lipids in Women >50 Years Undergoing Coronary Angiography: The Apo A1 Remnant Ratio (Apo A1/[VLDL3+IDL])*
|
Muhlestein, J. Brent
|
|
2011
|
5 |
3 |
p. 234
|
artikel
|
| 10 |
Apolipoprotein B Synthesis Inhibition by Mipomersen Reduces LDL-C When Added to Maximally Tolerated Lipid-Lowering Medication in Patients with Severe Heterozygous Hypercholesterolemia †
|
Tardif, Jean-Claude
|
|
2011
|
5 |
3 |
p. 219-220
|
artikel
|
| 11 |
Apolipoprotein E4 Pathophysiology, New Therapeutic Target?
|
Nash, David T.
|
|
2011
|
5 |
3 |
p. 197
|
artikel
|
| 12 |
Association Between Nonalcoholic Fatty Liver Disease and Aortic Atherosclerosis in a Healthy Population Older Than 40 Years
|
Lynch, Santiago
|
|
2011
|
5 |
3 |
p. 204-205
|
artikel
|
| 13 |
Atherogenic Properties of Selective and Nonselective Coxibs in THP-1 Human Monocytes/Macrophages
|
Voloshyna, Irina
|
|
2011
|
5 |
3 |
p. 209-210
|
artikel
|
| 14 |
Barriers to Non-HDL-Cholesterol Goal Attainment: Exploring the Gaps in Knowledge, Attitude, and Practices of Providers*
|
Virani, Salim S.
|
|
2011
|
5 |
3 |
p. 211-213
|
artikel
|
| 15 |
Baseline VLDL-C is Significantly Associated with Triglyceride Response to Treatment with Fenofibric Acid, Statins, or Their Combination* †
|
Joshi, Parag
|
|
2011
|
5 |
3 |
p. 228-229
|
artikel
|
| 16 |
Bimodal Distribution of Lipoprotein(a) in Carriers of the LPA 4399Met Allele LPA Genotype Correlates with Increased Lipoprotein(a) Levels
|
Baca, Arthur Martin
|
|
2011
|
5 |
3 |
p. 225-226
|
artikel
|
| 17 |
Changes in LDL-C Levels and Goal Attainment Associated with Adding Ezetimibe onto Simvastatin, Atorvastatin, and Rosuvastatin Versus Titrating Statins †
|
Foody, JoAnne M.
|
|
2011
|
5 |
3 |
p. 207-208
|
artikel
|
| 18 |
CIMT: Refining CVD Risk Prediction and Evaluation Effects of Lipid Therapies †
|
Doneen, Amy L.
|
|
2011
|
5 |
3 |
p. 227-228
|
artikel
|
| 19 |
Clinical perspective: Have the results of recent clinical trials of lipid-lowering therapies influenced the way we should practice? A Latin American perspective of current issues in clinical lipidology
|
Santos, Raul D.
|
|
2011
|
5 |
3 |
p. 124-132
|
artikel
|
| 20 |
Comparative Lipid Antioxidant Effects of Omega-3 Fatty Acids in Combination with HMG-CoA Reductase Inhibitors
|
Mason, Richard Preston
|
|
2011
|
5 |
3 |
p. 201
|
artikel
|
| 21 |
Comparison of Carotid Intima-Media Thickness in Pediatric Patients with Insulin Resistance Syndrome, Heterozygous Familial Hyperlipidemia, and Healthy Control Patients*
|
Vijayasarathi, Arvind
|
|
2011
|
5 |
3 |
p. 226
|
artikel
|
| 22 |
Correction of the Omega-3 Index in Women with Metabolic Syndrome by Adding Omega-3 Supplements to a Mediterranean Style Diet
|
Lerman, Robert Howard
|
|
2011
|
5 |
3 |
p. 224
|
artikel
|
| 23 |
Dalcetrapib Does Not Prevent CETP-Induced Pre-β1-HDL Formation, a Potential Marker of HDL Functionality, in Human Plasma In Vitro and in Treated Patients †
|
Niesor, Eric J.
|
|
2011
|
5 |
3 |
p. 216
|
artikel
|
| 24 |
Decreased Hospital Stay in Diabetics: Do Statins Help?* †
|
Bulchandani, Deepti
|
|
2011
|
5 |
3 |
p. 238-239
|
artikel
|
| 25 |
Dietary Supplement Use in Patients Enrolled in the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) Trial
|
Charland, Scott L.
|
|
2011
|
5 |
3 |
p. 223-224
|
artikel
|
| 26 |
Differences in the Predictive Ability of Apolipoprotein A1 for Future Death/Myocardial Infarction Among Men and Women Undergoing Coronary Angiography*
|
Muhlestein, J Brent
|
|
2011
|
5 |
3 |
p. 232-233
|
artikel
|
| 27 |
Dissociation of Apolipoprotein B, Low-Density Lipoprotein Cholesterol, and Non-High-Density Lipoprotein Cholesterol Targets in Patients Receiving Lipid
|
Guyton, John R.
|
|
2011
|
5 |
3 |
p. 205-206
|
artikel
|
| 28 |
Editorial Board
|
|
|
2011
|
5 |
3 |
p. iii-iv
|
artikel
|
| 29 |
Effect of Dalcetrapib and Torcetrapib on Noncholesterol Markers of Cholesterol Homeostasis in the Hamster
|
Niesor, Eric J
|
|
2011
|
5 |
3 |
p. 220
|
artikel
|
| 30 |
Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Low-Density Lipoprotein Cholesterol: A Critical Review
|
Jacobson, Terry
|
|
2011
|
5 |
3 |
p. 200-201
|
artikel
|
| 31 |
Effects of Fenofibric Acid in Combination with Statin Therapy on LDL and HDL Particle Number in Patients with Mixed Dyslipidemia †
|
Jones, Peter H.
|
|
2011
|
5 |
3 |
p. 202
|
artikel
|
| 32 |
Effects of 4 g/d Prescription Omega-3-Acid Ethyl Esters on Fasting and Postprandial Lipids and Indices of Glucose Homeostasis
|
Maki, Kevin Carl
|
|
2011
|
5 |
3 |
p. 237
|
artikel
|
| 33 |
Effects of lecithin: Cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels
|
Agirbasli, Deniz
|
|
2011
|
5 |
3 |
p. 152-158
|
artikel
|
| 34 |
Efficacy and Safety of Ezetimibe Plus Rosuvastatin Versus Rosuvastatin Up-Titration in Hypercholesterolemic Patients at Risk for Atherosclerotic Coronary Heart Disease
|
Bays, Harold Edward
|
|
2011
|
5 |
3 |
p. 217-218
|
artikel
|
| 35 |
Efficacy of Ezetimibe/Statins and Statin Monotherapy and Factors Associated with Treatment Response: Pooled Analysis of >21,000 Subjects from 27 Trials
|
Morrone, Doralisa
|
|
2011
|
5 |
3 |
p. 236-237
|
artikel
|
| 36 |
Efficacy Readout for PCSK9 Inhibition
|
Laaksonen, Reijo
|
|
2011
|
5 |
3 |
p. 222-223
|
artikel
|
| 37 |
Electronic Chart Review of A Multispecialty Internal Medicine Practice Evaluating Appropriate Identification of Patients with Familial Hyperlipidemia*
|
Gonzalez Santos, Lourdes Ella
|
|
2011
|
5 |
3 |
p. 229
|
artikel
|
| 38 |
Experience with Nondaily Dosing of Rosuvastatin, a Case Series*
|
Noor, Naosheen
|
|
2011
|
5 |
3 |
p. 220-221
|
artikel
|
| 39 |
Extended Release Niacin/Laropiprant Lowers Atherogenic Lipids Across Patient Subgroups
|
Bays, Harold Edward
|
|
2011
|
5 |
3 |
p. 239
|
artikel
|
| 40 |
Ezetimibe/Simvastatin + Extended Release Niacin Therapy Improves Attainment of Recommended Levels of LDL-C, Non-HDL-C, and ApoB in Hyperlipidemic Patients †
|
Fazio, Sergio
|
|
2011
|
5 |
3 |
p. 208-209
|
artikel
|
| 41 |
Ezetimibe/Simvastatin 10/40 mg Versus Atorvastatin 40 mg in High Cardiovascular Risk Patients with Primary Hypercholesterolemia
|
Triscari, Joseph
|
|
2011
|
5 |
3 |
p. 203
|
artikel
|
| 42 |
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
|
Goldberg, Anne C.
|
|
2011
|
5 |
3 |
p. 133-140
|
artikel
|
| 43 |
Favorable Effect of Helicobacter pylori on Serum Lipid Profile*
|
Manickam, Palaniappan
|
|
2011
|
5 |
3 |
p. 221-222
|
artikel
|
| 44 |
From the Editor
|
Brown, W. Virgil
|
|
2011
|
5 |
3 |
p. 121
|
artikel
|
| 45 |
Gene Polymorphism−Fish Oil Interactions in the Context of Cardiovascular Risk
|
Madden, Jaqueline
|
|
2011
|
5 |
3 |
p. 240
|
artikel
|
| 46 |
Greater Dissociation of Apolipoprotein B and LDL Cholesterol Targets in Diabetes Versus Nondiabetes Patients Receiving Lipid-Lowering Therapy
|
Brudi, Philippe D.P.
|
|
2011
|
5 |
3 |
p. 198-199
|
artikel
|
| 47 |
How Much Omega-3 is Needed to Achieve the Target Omega-3 Index?
|
Harris, William S.
|
|
2011
|
5 |
3 |
p. 211
|
artikel
|
| 48 |
Identification of a Novel Frame Shift Mutation of the LDL Receptor Gene Causing Familial Hypercholesterolemia in Omani Family*
|
Al-Waili, Khalid Ali
|
|
2011
|
5 |
3 |
p. 222
|
artikel
|
| 49 |
Inappropriate Use of Fibrate Therapy in a University-Based Primary Care Clinic Setting*
|
White, Jonathan R.
|
|
2011
|
5 |
3 |
p. 213
|
artikel
|
| 50 |
Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients
|
Farnier, Michel
|
|
2011
|
5 |
3 |
p. 179-187
|
artikel
|
| 51 |
Interrelationship of Lipids, Inflammatory Markers, and Coronary Artery Calcification Score in Patients with Chronic Ischemic Heart Disease
|
Burazor, Ivana
|
|
2011
|
5 |
3 |
p. 229-230
|
artikel
|
| 52 |
Lack of Association Between Helicobacter pylori Seropositivity and the Progression of Atherosclerosis in Healthy Adults*
|
Manickam, Palaniappan
|
|
2011
|
5 |
3 |
p. 221
|
artikel
|
| 53 |
LDL-Apheresis for Prevention of Recurrent Hypertriglyceridemia-Induced Acute Pancreatitis, A Case Report*
|
Saad, Andre
|
|
2011
|
5 |
3 |
p. 216-217
|
artikel
|
| 54 |
LDL-c, LDL-p, and Oxidized-LDL in Overweight Children
|
Ebert, James Ray
|
|
2011
|
5 |
3 |
p. 223
|
artikel
|
| 55 |
Lipids Apheresis: To Whom? When? And How?
|
Pokrovsky, Sergey N.
|
|
2011
|
5 |
3 |
p. 224-225
|
artikel
|
| 56 |
Lipid Target Attainment by Switching Statin Monotherapy to Fenofibric Acid + Statin in Patients with Mixed Dyslipidemia and at High-/Highest-Risk for Coronary Heart Disease
|
Jones, Peter H.
|
|
2011
|
5 |
3 |
p. 202-203
|
artikel
|
| 57 |
Long-term Effectiveness of a Therapeutic Lifestyle Change Program in Clinical Practice
|
Lerman, Robert Howard
|
|
2011
|
5 |
3 |
p. 237-238
|
artikel
|
| 58 |
Long-Term Effects of Fenofibric Acid + Statin Combination Therapy in Patients with High Triglycerides and Low HDL-C †
|
Thakker, Kamlesh
|
|
2011
|
5 |
3 |
p. 228
|
artikel
|
| 59 |
Lower LDL-C values Should Be Reached to Normalize Apolipoprotein B Concentrations in Hypertriglyceridemic Patients Receiving Lipid-lowering Therapy
|
Brudi, Philippe D.P.
|
|
2011
|
5 |
3 |
p. 199-200
|
artikel
|
| 60 |
Low Incidence of Paradoxical Reductions in HDL-C Levels in Dyslipidemic Patients Treated with Fenofibrate Alone or with Ezetimibe or EZE/Simvastatin
|
Brudi, Philippe D.P.
|
|
2011
|
5 |
3 |
p. 200
|
artikel
|
| 61 |
Metabolic Syndrome Prevalence and its Individual Risk Factors Characteristics in Population of Central Serbia
|
Burazor, Ivana
|
|
2011
|
5 |
3 |
p. 230
|
artikel
|
| 62 |
News from the NLA
|
|
|
2011
|
5 |
3 |
p. 122-123
|
artikel
|
| 63 |
Non-HDLC is Not Associated with Other Laboratory Measures of Atherogenic Risk
|
Superko, H. Robert
|
|
2011
|
5 |
3 |
p. 235
|
artikel
|
| 64 |
Omega 3 Fatty Acids but Not Exenatide Can Help Nonalcoholic Fatty Liver Disease* †
|
Nachnani, Jagdish S
|
|
2011
|
5 |
3 |
p. 206
|
artikel
|
| 65 |
Omega-3 Free Fatty Acids Demonstrate More Than 4-Fold Greater Bioavailability for EPA and DHA Compared with Omega-3-acid Ethyl Esters in Conjunction with a Low-Fat Diet: The ECLIPSE Study †
|
Kling, Douglas F.
|
|
2011
|
5 |
3 |
p. 231
|
artikel
|
| 66 |
Potential effects on clinical management of treatment algorithms on the basis of apolipoprotein-B/A-1 and total/high-density lipoprotein-cholesterol ratios
|
Vodnala, Deepthi
|
|
2011
|
5 |
3 |
p. 159-165
|
artikel
|
| 67 |
Potential Impact of a Lipoprotein(a)-Based Algorithm on Management of Patients Referred to a Lipid Clinic Vascular Dementia: The Silent Epidemic: The Role of Statins
|
Vodnala, Deepthi
|
|
2011
|
5 |
3 |
p. 198
|
artikel
|
| 68 |
Predicting Statin Induced Muscle Toxicity
|
Laaksonen, Reijo
|
|
2011
|
5 |
3 |
p. 239-240
|
artikel
|
| 69 |
Prediction of Angiographic Coronary Heart Disease Among Those with Normal LDL Levels Through the Use of a Novel Risk Score*
|
Muhlestein, J Brent.
|
|
2011
|
5 |
3 |
p. 231-232
|
artikel
|
| 70 |
Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease
|
Maki, Kevin C.
|
|
2011
|
5 |
3 |
p. 141-151
|
artikel
|
| 71 |
Presence of Family History of Coronary Artery Disease is Associated with a Higher Prevalence of Coronary Artery Calcium*
|
Kirkland, Ben
|
|
2011
|
5 |
3 |
p. 214-215
|
artikel
|
| 72 |
Prevalence of LDL Dyslipidemia, Assessment of Goal Attainment and Variables Associated with Goal Attainment in HIV+ Patients in a Dedicated HIV Clinic
|
Myerson, Merle
|
|
2011
|
5 |
3 |
p. 213-214
|
artikel
|
| 73 |
REGN727/SAR236553, a Fully-Human Monoclonal Antibody to Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Decreases ApoB and Non-HDL-C When Administered Intravenously to Healthy Volunteers
|
Swergold, Gary
|
|
2011
|
5 |
3 |
p. 219
|
artikel
|
| 74 |
Relationship Between HsCRP Reduction and LDL-C, Non-HDL-C, ApoB, and HDL-C in Hyperlipidemic Patients Treated with Ezetimibe/Simvastatin + Niaspan †
|
Brown, W. Virgil
|
|
2011
|
5 |
3 |
p. 206-207
|
artikel
|
| 75 |
Relative Effect of HDL-C and Triglycerides on the Risk of Microvascular Complications Following Type II Diabetes
|
Cziraky, Mark J.
|
|
2011
|
5 |
3 |
p. 210
|
artikel
|
| 76 |
Relative Impact of LDL-C and Non-HDL-C on the Risk of Microvascular Complications Following Type II Diabetes
|
Cziraky, Mark J.
|
|
2011
|
5 |
3 |
p. 210-211
|
artikel
|
| 77 |
Resveratrol Exerts Antiatherogenic Effects on Cholesterol Flux in THP-1 Human Monocytes/Macrophages
|
Reiss, Allison B.
|
|
2011
|
5 |
3 |
p. 226-227
|
artikel
|
| 78 |
Safety Profile of Statins Alone or Combined with Ezetimibe: A Pooled Analysis of Over 21,000 Patients
|
Toth, Peter P.
|
|
2011
|
5 |
3 |
p. 204
|
artikel
|
| 79 |
Small, Dense LDL-Cholesterol is More Predictive Than Traditional Lipoproteins of Angiographic CAD in Females*
|
Laury, Torrance
|
|
2011
|
5 |
3 |
p. 215
|
artikel
|
| 80 |
Specific Increase in Fasting Morning Glucose in Normoglycemic Patients Treated with Niacin and with Statins
|
Guyton, John R.
|
|
2011
|
5 |
3 |
p. 234
|
artikel
|
| 81 |
Table of Contents
|
|
|
2011
|
5 |
3 |
p. v-vi
|
artikel
|
| 82 |
The Benefit of Statins on Cardiovascular Events: Relative Contribution of LDL Reduction and Pleiotropic Effects
|
Kostis, John B.
|
|
2011
|
5 |
3 |
p. 218-219
|
artikel
|
| 83 |
The Efficacy and Safety of Rosuvastatin 5mg in Statin Intolerant Patients: An Observational Study
|
Wierzbicki, Anthony S.
|
|
2011
|
5 |
3 |
p. 235-236
|
artikel
|
| 84 |
The High-Dose Rosuvastatin Once Weekly Study (HD-ROWS)
|
Backes, James M.
|
|
2011
|
5 |
3 |
p. 216
|
artikel
|
| 85 |
The population effects of the global cardiovascular risk model in United States Adults: Findings from the National Health and Nutrition Surveys, 2005–2006
|
Tattersall, Matthew C.
|
|
2011
|
5 |
3 |
p. 166-172
|
artikel
|
| 86 |
Two Single Nucleotide Polymorphisms in the Apolipoprotein(a) Gene are Predictors of the Risk of Coronary Heart Disease
|
Li, Yonghong
|
|
2011
|
5 |
3 |
p. 201-202
|
artikel
|
| 87 |
Use of Noninvasive Combined MRI-PET/CT Imaging in dal-PLAQUE to Assess Dalcetrapib's Effects on Structural and Inflammatory Atherosclerotic Disease
|
Fayad, Zahi A.
|
|
2011
|
5 |
3 |
p. 240-241
|
artikel
|
| 88 |
Vascular Dementia: The Silent Epidemic: The Role of Statins
|
Nash, David T.
|
|
2011
|
5 |
3 |
p. 197-198
|
artikel
|
Tijdschrift beschrijving